(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol

CAS: 127852-28-2

Ref. TR-B416125

Produktinformation

• Name: (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
• Synonyme: (alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)-Benzenemethanol, (1R)-1-[3,5-Bis(Trifluoromethyl)phenyl]ethanol, (1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethan-1-ol, (1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethanol, (R)-1-(3,5-Bis(Trifluoromethyl)Phenyl)Ethan-1-Ol, (R)-1-(3,5-Bis-trifluoromethylphenyl)ethanol, (R)-1-3,5-Bis(trifluoromethyl) phenylethanol, (R)-1-[3,5-Bis(Trifluoro-Methyl)-Phenyl]Ethanol, (R)-1-[Bis-3,5-(Trifluoromethyl)Phenyl]Ethanol, (R)-[3,5-Bis(trifluoromethyl)phenyl]ethanol, (R)-bis-3,5-trifluoromethyl-1-phenylethanol, (αR)-α-Methyl-3,5-bis(trifluoromethyl)benzenemethanol, 1-[3,5-Bis(Trifluoromethyl)Phenyl]Ethanol, 1R)-1-[3,6-Bis(Trifluoromethyl)Phenyl]Ethanol, Aprepitant Intermediate, Benzenemethanol, A-Methyl-3,5-Bis(Trifluoromethyl)-, (Ar)-, Benzenemethanol,a-methyl-3,5-bis(trifluoromethyl)-,(R)-, R-Mbt-Pel

Beschreibung

Applications (R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol is an intermediate in the synthesis of Aprepitant (A729800), a novel selective neurokinin-1 (NK-1) receptor antagonist. In vitro studies using human liver microsomes indicate that Aprepitant is metabolised primarily by CYP3A4 with minor metabolism by CYP1A2 and CYP2C19, and no metabolism by CYP2D6, CYP2C9, or CYP2E1. Antiemetic.
References Vankawala, P.J., et. al.: Synthetic Comm., 37, 3439 (2007); Hale, J.J., et al.: J. Med. Chem., 41, 4607 (1998); Campos, D., et al.: J. Clin. Oncol., 19, 1759 (2001); Van Belle, S., et al.: Cancer, 94, 3032 (2002); Majumdar, A.K., et al.: J. Clin. Pharmacol., 46, 291 (2006)

• Marke: TRC

Chemische Eigenschaften

• Molekulargewicht: 258.16
• Formel: C₁₀H₈F₆O
• Farbe/Form: Neat
• InChl: InChI=1S/C10H8F6O/c1-5(17)6-2-7(9(11,12)13)4-8(3-6)10(14,15)16/h2-5,17H,1H3/t5-/m1/s1
• InChI Key: InChIKey=MMSCIQKQJVBPIR-RXMQYKEDSA-N
• SMILES: C[C@@H](O)c1cc(C(F)(F)F)cc(C(F)(F)F)c1